Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
40 Cards in this Set
- Front
- Back
Name/describe two types of receptors
|
Ionotropic/ligand gated ion channels - have an ion channel that opens when a transmitter binds
Metabotropic Receptors - activate G proteins with transmitter attachment, alpha unit attaches to other channel. Slower |
|
Function of ligands
|
bind to receptors
activate receptors block receptors |
|
Name/describe 2 main groups of ligands
|
Endogenous (natural body chemicals) - neurotransmitters, hormones (gaba, glu, dopamine)
Exogenous - outside the body - drugs, toxins (activates same receptor as EG NT) |
|
Chemicals that fit the cholinergic receptor can be (2 types)
|
Antagonists - block ACh receptors (curare and bungarotoxin)
Agonists - mimic ACh (nicotine) |
|
Morphine interacts with what receptor?
|
endogenous opiate receptors
|
|
What do antagonists do?
|
1) competitive antagonist blocks same site as endogenous transmitter
2) Transmitter binds, but does not activate (it's blocked)!! OR Noncompetitive antagonist binds to another site, transmitter binds but cannot activate since it's blocked |
|
Three important characteristics about drug targets
|
1) Drugs are ligands that act upon specific receptors
2) Drugs can target one or a few receptor subtypes 3) Since receptor subtypes can have different localizations and functions, drug actions can have widely varying effects |
|
Define "drugs"
|
Substances with pronounces effects in small quantities, interacting with receptors or metabolic processes related to synaptic transmission
|
|
the dose response curve shows
|
Relationship between drug dose and effects (+ drug = + effect, levels out)
ED50 is lower on more potent drug Graphed as Log dose VS Response |
|
Lock and key model
|
each hormone/NT/drug has one place to fit
|
|
Name potential sites of action - Presynaptic (8)
|
1. Interfere with syntehsis of NT
2. Block AP from going into terminal (ex: block vgated Na+ channels) 3. Block axonal transport of resources into terminal??? 4. Disrupt normal NT release (block Ca++ channels, deplete NT?) 5. Interfere w/ packaging of NT into vesicles (ex: leaky vesicles) 6. Modulate (enhance/block) NT release (blocking presynaptic receptors so they can't inhibit??) 7. Interfere with presynaptic reuptake of neurotransmitters 8. Block normal breakdown of NT (ex: mess with enzymes) |
|
Name potential sites of action - Post-synaptic (5)
|
1. Degradation of transmitter (prolong effects, don't break NT down)
2. Alter # of postsynaptic receptors 3. Blockade (antagonize) of receptors 4. Activate receptors 5. Interfere w/ metabotropic signaling cascade (2nd messenger/Gprotein)? |
|
Why do we care about all these sites?
|
Drugs are important for health and illness
Many drugs are abused. Sites of action offer insight to understand abuse mechanisms and may offer potential treatment clues Drugs are hard to deliver and target accurately. Alternative action locations may facilitate therapeutic applications |
|
Name 4 types of NT and examples of each
|
1) Amine NT - acetylcholine, dopamine, seratonin
2) Amino acid NT - GABA, glutamate 3) Peptide NT - Substance P, small chain of Amino acids 4) Gas NT - NO |
|
Important facts about Acetylcholine
|
First NT discovered (in heart)
Source neurons in basal forebrain w/widespread projections to cortex and subcortical brain regions Alzheimer's = loss of ACh It's important for memory and learning, attention Created in basal forebrain and peduncolopontine nucleus (small nuclei deep in brain) |
|
Name two types of ACh receptors??
|
1) Nicotonic - most are ionotropic and excitatory (muscles receptors, curare can paralyze)
2) Muscarinic - metabotropic type, either excitatory/inhibitory Muscarinic blockade by scopolamine (seasickness) changes cognition |
|
Nicotine effects
|
Increases heart rate, blood
pressure, hydrochloric acid secretion, and bowel activity Agonist on nicotinic ACh receptors in the ventral tegmental area (reward region) |
|
Monoamines (types , where they are located, function)
|
Domamine, Seratonin, Norepinepherine
Located in small nuclei of midbrain Have widespread projections in brain Role in movement/reward mechanisms |
|
Function of noradregenic pathways
|
Modulate mood, arousal, sexual behavior
|
|
Function of seratonergic (5-HT) pathways
|
Sleep, sexual behavior, anxiety, etc. Anti-depressents increase 5HT activity
|
|
Glutamate/Asparate
|
•Glutamate is the most common transmitter in the brain – no particular pathway
• Glutamate acts on AMPA,kainate, and NMDA receptors as well as mGluRs, which are slower metabotropic receptors • Glutamate can be toxic removed from the synapse by glial astrocytes Can cause damage, like in strokes and huntingtons disease (too much glu overactivates neurons so they burn out) |
|
GABA/Glycine
|
• Inhibitory transmitters widespread in brain and spinal cord
• GABAA–ionotropic, producing fast, inhibitory effects • GABA agonists, like Valium, are potent tranquilizers |
|
Peptide transmitters
|
Small protein peptides
• Numerous types often co-released with other transmitters • Typically slow actions (i.e., thought to be modulatory) • Endogenous form of opioids i.e., they are naturally occurring “opiates” –like “unnatural” morphine • They act at endogenous opioid receptors of various types in brain and gut |
|
Endocannibinoid (THC)
|
Brian contains Endocannibinoid (ex: anadamine) and receptors
• Alters memory formation • Appetite stimulation • Reduced pain sensitivity • Protection from excitotoxic brain damage |
|
Dopamine has a role in...
|
reward, drug abuse
Experiment w/ animals self administering (using microdialysis tube w/semiperm membrane and normal salt concentration in nucleus accumbens, measure) Dopamine release increases with self administration of cocaine |
|
Drugs stats
|
(See graph, probably don't need to memorize)
Full time college students more likely to binge drink |
|
Study
|
Charts of drug spread in brain
|
|
Benzodiazapene
|
agonist tranculizer, has binding site on GABA
|
|
Picrotoxin
|
Poison that blocks gaba receptor , has binding site on GABA
|
|
Barbituates
|
Sedating drugs w/ binding site on GABA
|
|
Explain GABA alosteric modulation **
|
Steroid binds to GABA receptor (with GABA already attached), enhances effects so channel is more open
Causes IPSP/prevents EPSPs -drags down to resting potentials Benzodiazapene/barbiturates also work this way?? |
|
Inverse agonists
|
causes channel to do opposite of what it does
(ex:on benzodiazapene site to make it anxiogenic - treats overdoses) |
|
Binding affinty
|
how strongly attached a drug/NT is, how long it stays
|
|
Describe the dopamine projections
|
1) Mesolimbocortical pthwy: VTA to nucelus accumbens, cortex, hippocampus
2) Mesostriatial pthwy: substantia nigra to striatium (caudate and putamen) |
|
The striatium is made up of...
|
the caudate and putamen
|
|
Describe noradrenergic pathway
|
Created in lateral tegmental area, spreads to:
1) cerebellum 2) locus corulus (to hippocampus, basal ganglia, cortex) 3) spinal cord |
|
Describe the seratonergic (5HT) pathway
|
Created in raphe nuclei, spreads to:
1) Mesencephalic serotenergic cells, which project to thalamus, hypothalamus, basal ganglia, cortex 2) to spinal cord 3) to cerebellum 4) to hippocampus |
|
L-dopa
|
drug that causes cells to Increase dopamine production
This is the main treatment options, but it wears off |
|
What disorder is linked with dopamine?
|
Dopamine dies in parkinsons, so treatment is to administer dopamine agonists. May have bad side effects (gambling, etc) since it alters the reward system
Substantia nigra dies in parkinsons |
|
GO OVER
|
MOUSE PARTY + PATHWAYS!!
|